BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33926265)

  • 1. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
    Li Z; Xu H; Yu J; Liu C; Zheng C; Zeng R; Xu L; Li E; Peng Y; Xu Y
    Cancer Control; 2021; 28():10732748211004883. PubMed ID: 33926265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma.
    Liu CT; Xu YW; Guo H; Hong CQ; Huang XY; Luo YH; Yang SH; Chu LY; Li EM; Peng YH
    Gut Liver; 2020 Nov; 14(6):727-734. PubMed ID: 31822054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Levels of L1-cell Adhesion Molecule as a Serum Biomarker for Early Detection of Gastric Cancer and Esophagogastric Junction Adenocarcinoma.
    Chu LY; Peng YH; Yang T; Fang WK; Hong CQ; Huang LS; Xu LY; Li EM; Xu YW; Xie JJ
    J Cancer; 2020; 11(18):5395-5402. PubMed ID: 32742486
    [No Abstract]   [Full Text] [Related]  

  • 6. Value of exhaled hydrogen sulfide in early diagnosis of esophagogastric junction adenocarcinoma.
    Liu F; Wei L; Zheng B; Su X; Ju J; Liu G; Liu Q
    Oncol Lett; 2024 Jul; 28(1):321. PubMed ID: 38807679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma.
    Ding TY; Peng YH; Hong CQ; Huang BL; Liu CT; Luo Y; Chu LY; Zhang B; Li XH; Qu QQ; Xu YW; Wu FC
    Discov Oncol; 2022 Nov; 13(1):128. PubMed ID: 36409444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
    Han R; Chen G; Li M; Peng ZM; Xu L
    Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor.
    Chu LY; Zhou JY; Zhao YX; Ou YT; Yang T; Peng YH; Fang WK; Xu YW; Xie JJ
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
    Huang Z; Zhou B; Li Z; Liu C; Zheng C; Zeng R; Hong C; Xu L; Li E; Peng Y; Xu Y
    Cancer Biomark; 2020; 29(1):139-149. PubMed ID: 32623391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
    World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Chen H; Chen Y; Yeung SC; Zhang H
    Int J Cancer; 2015 Apr; 136(7):1636-45. PubMed ID: 25159681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor-associated glycoprotein 72, a helpful predictor of lymph nodes invasion in esophagogastric junction adenocarcinoma.
    Xu Y; Chen Y; Wei L; Lai S; Zheng W; Wu F
    Biochem Biophys Res Commun; 2019 Jan; 509(1):133-137. PubMed ID: 30579602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour.
    Xu YW; Chen H; Hong CQ; Chu LY; Yang SH; Huang LS; Guo H; Chen LY; Liu CT; Huang XY; Lin LH; Chen SL; Wu ZY; Peng YH; Xu LY; Li EM
    EBioMedicine; 2020 Jan; 51():102566. PubMed ID: 31901863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
    Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
    Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer].
    Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux.
    Liu FX; Wang WH; Wang J; Li J; Gao PP
    Helicobacter; 2011 Feb; 16(1):66-77. PubMed ID: 21241415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.